CompletedPhase 4NCT03788343
Phenylalanine and Its Impact on Cognition
Studying Disorder of phenylalanin or tyrosine metabolism
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Insel Gruppe AG, University Hospital Bern
- Principal Investigator
- Regula Everts, Prof. Dr. phil.Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism (UDEM), Inselspital, Bern University Hospital
- Intervention
- Phenylalanine(dietary_supplement)
- Enrollment
- 90 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2019 – 2022
Study locations (1)
- Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism (UDEM), Inselspital, Bern University Hospital, Bern, Switzerland
Collaborators
University of Zurich
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03788343 on ClinicalTrials.gov